Renal Tubular Acidosis Secondary to FK506 in Living Donor Liver Transplantation: A Case Report
FK506 is an immunosuppressant that is thought to be less nephrotoxic than cyclosporine A. However, complications due to renal tubular acidosis (RTA) have recently been reported. We report a case of RTA secondary to FK506 administration in liver transplantation. A 6-month-old girl was treated with FK...
Main Authors: | Keiko Ogita, Narito Takada, Tomoaki Taguchi, Sachiyo Suita |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2003-10-01
|
Series: | Asian Journal of Surgery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958409603079 |
Similar Items
-
Allogeneic Hepatocyte Transplantation Using FK 506
by: P.M. Markus, et al.
Published: (1997-01-01) -
Sarcoma de Kaposi em paciente transplantada renal em uso de Fk-506 Kaposi's Sarcoma in a renal transplant patient receiving Fk-506
by: Jorge David Rocha Zanol, et al.
Published: (2002-12-01) -
Experimental Study Concerning Safety Dosage of OK-432 for Intrauterine Treatment
by: Keiko Ogita, et al.
Published: (2006-07-01) -
On the neuroprotective actions of FK506
by: Macleod, Malcolm
Published: (2001) -
Eye drops of FK506 and FK506 prodrugs based on chitosan to improve solubility and stability
by: Young-Guk Na, et al.
Published: (2012-01-01)